Biomedicines (Nov 2018)

HSP70 Inhibitor Suppresses IGF-I-Stimulated Migration of Osteoblasts through p44/p42 MAP Kinase

  • Tetsu Kawabata,
  • Haruhiko Tokuda,
  • Go Sakai,
  • Kazuhiko Fujita,
  • Rie Matsushima-Nishiwaki,
  • Gen Kuroyanagi,
  • Takanobu Otsuka,
  • Osamu Kozawa

DOI
https://doi.org/10.3390/biomedicines6040109
Journal volume & issue
Vol. 6, no. 4
p. 109

Abstract

Read online

Heat shock protein 70 (HSP70) is a ubiquitously expressed molecular chaperone in a variety of cells including osteoblasts. We previously showed that insulin-like growth factor-I (IGF-I) elicits migration of osteoblast-like MC3T3-E1 cells through the activation of phosphatidylinositol 3-kinase/Akt and p44/p42 mitogen-activated protein (MAP) kinase. In the present study, we investigated the effects of HSP70 inhibitors on the IGF-I-elicited migration of these cells and the mechanism involved. The IGF-I-stimulated osteoblast migration evaluated by a wound-healing assay and by a transwell cell migration was significantly reduced by VER-155008 and YM-08, which are both HSP70 inhibitors. VER-155008 markedly suppressed the IGF-I-induced phosphorylation of p44/p42 MAP kinase without affecting that of Akt. In conclusion, our results strongly suggest that the HSP70 inhibitor reduces the IGF-I-elicited migration of osteoblasts via the p44/p42 MAP kinase.

Keywords